Demyelinating plaques in relapsing-remitting and secondary-progressive multiple sclerosis: Assessment with diffusion MR imaging

American Journal of Neuroradiology

Volumn 21, Issue 5, 2000, Pages 862-868

  Scanderbeg, Alessandro Castriota ^a,c   Tomaiuolo, Francesco ^a   Sabatini, Umberto ^a   Nocentini, Ugo ^b   Grasso, Maria G ^a   Caltagirone, Carlo ^b  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c IRCCSS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DEMYELINATING DISEASE; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RECURRENT DISEASE; SCORING SYSTEM;

ADOLESCENT; ADULT; BRAIN; DIFFUSION; FEMALE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; MYELIN SHEATH; NEUROLOGIC EXAMINATION; REPRODUCIBILITY OF RESULTS;

EID: 0034065723     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Rudik RA, Cohen JA, Weinstock-Guttman B, Kinkel RP, Ransoholf RM. Management of multiple sclerosis. N Engl J Med 1997; 337:1604-1611
2. Van Waesberghe JHTM, Castelijns JA, Scheltens P, et al. Comparison of four potential MR parameters for severe tissue destruction in multiple sclerosis lesions. Magn Reson Imaging 1997;15:155-162
3. Miller D, Grossman RI, Reingold SC, McFarland HF. The role of magnetic resonance techniques in understanding and man-aging multiple sclerosis. Brain 1998;121:3-24
4. van Walderveen MA, Barkhof F, Hommes OR, et al. Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weightedl spin-echo images. Neurology 1995;45:1684-1690
5. Lycklama à Nijeholt GJ, van Walderveen MAA, Castelijns JA, et al. Brain and spinal cord abnormalities in multiple sclerosis: correlation Between MRI parameters, clinical subtypes and symptoms. Brain 1998;121:687-697
6. Arnold DL, Riess GT, Matthews PM, et al. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Ann Neurol 1994;36:76-82
7. Losseff NA, Webb SL, O'Riordan JI, et al. Spinal cord atrophy and disability in multiple sclerosis: a new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 1996a;;119:701-708
8. Le Bihan D. Molecular diffusion nuclear magnetic resonance imaging. Magn Reson Q 1991;7:1-30
9. Horsfield MA, Lai M, Webb SL, et al. Apparent diffusion coefficient in benign and secondary progressive multiple sclerosis by nuclear magnetic resonance. Magn Reson Med 1996;36:393-400
10. Poser CM, Paly DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231
11. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33: 1444-1452
12. Lublin FD, Reigned SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996;46:907-911
13. Stejskal EO, Tanner JE. Spin diffusion measurements: spin-echoes in the presence of a time-dependent field gradient. J Chem Phys 1965;42:288-292
14. Basser PJ, Mattiellu J, Le Bihan D. MR diffusion tensor spectroscopy and imaging. Biophys J 1994;66:259-267
15. Mattiello J, Basser PJ, Le Bihan D. The b matrix in diffusion tensor echo-planar imaging. Magn Reson Med 1997;37:292-300
16. Pierpaoli C, Jezzard P, Basser PJ, Barnett A, Di Chiro G. Diffusion tensor MR imaging of the human brain. Radiology 1996; 201:637-648
17. Basser PJ. Inferring microstructural features and the physiological state of tissues from diffusion-weighted images. NMR Biomed 1995;8:333-344
18. Minderhoud JM. On the pathogenesis of multiple sclerosis: a revised model of the cause(s) of multiple sclerosis, especially based on epidemiological data. Clin Neurol Neurosurg 1994;96: 135-142
19. Barnes D, Munro PM, Youl BD, Prineas JW, McDonald WI. The longstanding multiple sclerosis lesion: a quantitative MRI and electron microscopic study. Brain 1991;114:1271-1280
20. Sinnige LG, Teeuwissen E, Hew JM, Minderhoud JM. Correlation between magnetic resonance imaging and clinical parameters in multiple sclerosis. Acta Neurol Scand 1995;91:188-191
21. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278-285
22. De Stefano N, Matthews PM, Antel JP, Preul M, Francis G, Arnold DL. Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann Neurol 1995;38:901-909
23. Paty DW, Li DK. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis, II: MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC Multiple Selerosis/MRI Study Group and the IFNB Multiple Selerosis Study Group. Neurology 1993;43:662-667
24. Filippi M, Paty DW, Kappos L, et al. Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study. Neurology 1995;45:255-260
25. Thorpe JW, Kidd D, Moseley IF, et al. Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis. Neurology 1996;46:373-378
26. Truyen L, van Waesberghe JH, van Walderveen MA, et al. Accumulation of hypointense lesions ("black holes") on T1 spinecho MRI correlates with disease progression in multiple selerosis. Neurology 1996;47:1469-1476
27. Dousset V, Grossman RI, Ramer KN, et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992;182: 483-491
28. Loevner LA, Grossman RI, Cohen JA, Lexa FJ, Kessler D. Kolson DL. Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. Radiology 1995b;;196:511-515
29. Loevner LA, Grossman RI, McGowan JC, Ramer KN, Cohen JA. Characterization of multiple sclerosis plaques with T1-weighted MR and quantitative magnetization transfer. AJNR Am J Neuroradiol 1995a;;16:1473-1479
30. Simmons ML, Frondoza CG, Coyle JT. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 1991;45:37-45
31. van Walderveen MA, Scheltens P, Barkhof F, et al. Histopathologic correlates of hypointense lesions on T1-weighted SE MR images in multiple sclerosis [abstract]. J Neurol 1996;243(Suppl 2):S18
32. Hiehle JF Jr, Lenkinski RE, Grossman RI, et al. Correlation of spectroscopy and magnetization transfer imaging in the evaluation of demyelinating lesions and normal appearing white matter in multiple sclerosis. Magn Reson Med 1994;32:285-293
33. Pike GB, de Stefano N, Narayanan S, Francis GS, Antel JP, Arnold DL. Combined magnetization transfer and proton spectroscopy imaging in the assessment of pathologic brain lesions in multiple sclerosis. AJNR Am J Neuroradiol 1999;20:829-837
34. Van Walderveen MAA, Barkhof F, Pouwels PJ, van Schijndel RA, Polman CH, Castelijns JA. Neuronal damage in T1-hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy. Ann Neurol 1999;46:79-87
35. Van Waesherghe JHTM, van Walderveen MAA, Castelijns JA, et al. Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. AJNR Am J Neuroradiol 1998;19:675-683
36. Larsson HBW, Thomsen C, Frederiksen J, Stubgaard M, Henriksen O. In vivo magnetic resonance diffusion measurement in the brain of patients with multiple sclerosis. Magn Reson Imaging 1992;10:7-12
37. Christiansen P, Gideon P, Thomsen C, et al. Increased water self-diffusion in chronic plaques and in apparently normal white matter in patients with multiple sclerosis. Acta Neurol Scand 1993;87:195-199
38. Werring DJ, Clark CA, Barker GJ, Thompson AJ, Miller DH. Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology 1999;52:1626-1632
39. Pierpaoli C, Basser PJ. Toward a quantitative assessment of diffusion anisotropy [published erratum appears in Magn Reson Med 1997;37:972]. Magn Reson Med 1996;36:893-906